New Research Coverage Highlights East West, Heron

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
62
New Research Coverage Highlights East West, Heron Therapeutics, Invacare, CNO Financial Group, Fortinet, and Realogy — Consolidated Revenues, Company Growth, and Expectations for 2018

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of East West Bancorp, Inc. (NASDAQ: EWBC ), Heron Therapeutics, Inc. (NASDAQ: HRTX ), Invacare Corporation (NYSE: IVC ), CNO Financial Group, Inc. (NYSE: CNO ), Fortinet, Inc. (NASDAQ: FTNT ), and Realogy Holdings Corp. (NYSE: RLGY ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EWBC DOWNLOAD: http://Fundamental-Markets.com/register/?so=EWBC HRTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=HRTX IVC DOWNLOAD: http://Fundamental-Markets.com/register/?so=IVC CNO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CNO FTNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=FTNT RLGY DOWNLOAD: http://Fundamental-Markets.com/register/?so=RLGY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine East West Bancorp, Inc. (NASDAQ: EWBC ), Heron Therapeutics, Inc. (NASDAQ: HRTX ), Invacare Corporation (NYSE: IVC ), CNO Financial Group, Inc. (NYSE: CNO ), Fortinet, Inc. (NASDAQ: FTNT ), and Realogy Holdings Corp. (NYSE: RLGY ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 9th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EAST WEST BANCORP, INC. (EWBC) REPORT OVERVIEW

East West's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, East West reported interest income of $400.31MM vs $322.78MM (up 24.02%) and basic earnings per share $1.19 vs $0.82 (up 45.12%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, East West reported interest income of $1,325.12MM vs $1,137.48MM (up 16.50%) and basic earnings per share $3.50 vs $3.00 (up 16.67%). East West is expected to report earnings on October 18th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.89. The estimated EPS forecast for the next fiscal year is $5.09 and is expected to report on January 24th, 2019.

To read the full East West Bancorp, Inc. (EWBC) report, download it here: http://Fundamental-Markets.com/register/?so=EWBC

-----------------------------------------

HERON THERAPEUTICS, INC. (HRTX) REPORT OVERVIEW

Heron Therapeutics' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Heron Therapeutics reported revenue of $17.28MM vs $8.51MM (up 103.02%) and basic earnings per share -$0.54 vs -$0.80. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Heron Therapeutics reported revenue of $30.77MM vs $1.28MM (up 2,305.55%) and basic earnings per share -$3.65 vs -$4.56. Heron Therapeutics is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.77. The estimated EPS forecast for the next fiscal year is -$0.66 and is expected to report on February 26th, 2019.

To read the full Heron Therapeutics, Inc. (HRTX) report, download it here: http://Fundamental-Markets.com/register/?so=HRTX

-----------------------------------------

INVACARE CORPORATION (IVC) REPORT OVERVIEW

Invacare's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Invacare reported revenue of $246.15MM vs $233.52MM (up 5.41%) and basic earnings per share -$0.50 vs -$0.72. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Invacare reported revenue of $966.50MM vs $1,047.47MM (down 7.73%) and basic earnings per share -$2.34 vs -$1.32. Invacare is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$0.24 and is expected to report on February 6th, 2019.

To read the full Invacare Corporation (IVC) report, download it here: http://Fundamental-Markets.com/register/?so=IVC

-----------------------------------------

CNO FINANCIAL GROUP, INC. (CNO) REPORT OVERVIEW

CNO Financial Group's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, CNO Financial Group reported revenue of $1,046.30MM vs $1,057.10MM (down 1.02%) and basic earnings per share $0.62 vs $0.49 (up 26.53%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CNO Financial Group reported revenue of $4,297.20MM vs $3,985.10MM (up 7.83%) and basic earnings per share $1.03 vs $2.03 (down 49.26%). CNO Financial Group is expected to report earnings on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.45. The estimated EPS forecast for the next fiscal year is $2.20 and is expected to report on February 12th, 2019.

To read the full CNO Financial Group, Inc. (CNO) report, download it here: http://Fundamental-Markets.com/register/?so=CNO

-----------------------------------------

FORTINET, INC. (FTNT) REPORT OVERVIEW

Fortinet's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Fortinet reported revenue of $441.30MM vs $363.50MM (up 21.40%) and basic earnings per share $0.29 vs $0.13 (up 123.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Fortinet reported revenue of $1,494.93MM vs $1,275.44MM (up 17.21%) and basic earnings per share $0.18 vs $0.19 (down 5.26%). Fortinet is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $1.14 and is expected to report on February 4th, 2019.

To read the full Fortinet, Inc. (FTNT) report, download it here: http://Fundamental-Markets.com/register/?so=FTNT

-----------------------------------------

REALOGY HOLDINGS CORP. (RLGY) REPORT OVERVIEW

Realogy's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Realogy reported revenue of $1,820.00MM vs $1,793.00MM (up 1.51%) and basic earnings per share $0.97 vs $0.79 (up 22.78%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Realogy reported revenue of $6,114.00MM vs $5,810.00MM (up 5.23%) and basic earnings per share $3.15 vs $1.47 (up 114.29%). Realogy is expected to report earnings on November 2nd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.70. The estimated EPS forecast for the next fiscal year is $2.20 and is expected to report on February 26th, 2019.

To read the full Realogy Holdings Corp. (RLGY) report, download it here: http://Fundamental-Markets.com/register/?so=RLGY

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com .

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com  

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com .

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Coke Florida's Commitment to Coastal Cleanliness Shines Bright

Updated Category News Views 141

Coke Florida's Volunteer Contributions for Coastal Cleanup Day Coca-Cola Beverages Florida, LLC (Coke Florida) was excited to take part in the worldwide celebration of International Coastal Cleanup (ICC) Day. This initiative, which focuses on sustainability and building community resilience, encouraged employees across the company's vast market to unite for a meaningful...

Continue Reading
LifeMD's Growth Momentum: Strong Earnings and Legal Support

Updated Category News Views 96

LifeMD Maintains Buy Rating Amid Positive Developments BTIG has reaffirmed its support for LifeMD Inc (NASDAQ: LFMD) by maintaining a Buy rating and a price target of $12.00 for the company’s stock. This endorsement comes at a pivotal time as the company experiences recent developments in the ongoing legal proceedings regarding tirzepatide, a drug used for treating type...

Continue Reading
Innovative Electric Heating Pad Adapter Set to Transform Comfort

Updated Category News Views 120

Innovative Heating Pad Adapter for Vehicles Inventors continuously strive to enhance daily experiences, and one such innovation is set to revolutionize comfort during travel. An inventor, inspired by the need for warmth while driving, developed the RIDE ALONG PRONG PLUG IN, a unique electric heating pad adapter accessible through a vehicle's cigarette lighter socket....

Continue Reading
Hang Feng Capital's Innovations Shine at Asia’s FinTech Hub

Updated Category News Views 158

Hang Feng Capital Excels at Hong Kong FinTech Week Recently, a remarkable event unfolded in the heart of Asia's financial landscape as Hang Feng Capital showcased its innovations during Hong Kong FinTech Week. Co-hosted by the local government and InvestHK, this pivotal event brought together over 700 exhibitors, 800 speakers, and an impressive crowd of 37,000 attendees...

Continue Reading
Autoliv Inc. Adjusts Revenue Forecast Amid Changing Market

Updated Category News Views 60

Autoliv Inc. got slapped with a serious reality check back in 2024 when JPMorgan revised its price target to $119, up just a hair from $117. You could feel the desks twitching as analysts dove into the automotive safety systems market, flagging Autoliv’s shaky standing amidst some forecasted storms brewing on the horizon. Global light vehicle production was supposed to...

Continue Reading